PUBLISHER: Grand View Research | PRODUCT CODE: 1986352
PUBLISHER: Grand View Research | PRODUCT CODE: 1986352
U.S. Chemical Indicators Market Size, Share & Trends Analysis Report By Product, By Method, By End-use, And Segment Forecasts, 2026 - 2033
U.S. Chemical Indicators Market Summary
The U.S. chemical indicators market size was estimated at USD 156.43 million in 2025 and is projected to reach USD 222.73 million by 2033, growing at a CAGR of 4.59% from 2026 to 2033. The market is driven by stringent sterilization regulations and compliance requirements across healthcare facilities.
Rising surgical procedure volumes and the growing number of outpatient and dental centers increase the demand for routine sterilization monitoring. Increased focus on infection prevention and patient safety further supports consistent use of chemical indicators. In addition, the adoption of advanced sterilization technologies is creating demand for specialized indicator products.
The increasing awareness of infection prevention continues to drive the U.S. market for chemical indicators, as healthcare facilities strengthen sterilization monitoring to reduce hospital-acquired infections. Greater emphasis on patient safety and regulatory compliance has led to routine validation of sterilization cycles using chemical indicators across hospitals, laboratories, and surgical centers. For instance, in September 2025, Infection Control Today underscored the critical role of medical device sterility in patient safety, highlighting steam sterilization as the most widely used method and emphasizing the importance of chemical indicators in verifying process effectiveness. The article also referenced ISO 11140-1 standards and compared Type 4 and Type 5 indicators, outlining their performance characteristics and role in ensuring compliant sterilization practices.
According to ISO 11140-1, Type 4 chemical indicators are designed to react to two or more critical sterilization process variables. In comparison, Type 5 chemical indicators respond to all critical variables and are formulated to more closely mimic the performance of a biological indicator (BI). For moist heat sterilization, these variables generally include exposure time and temperature in saturated steam, such as 132°C for 4 minutes. The standard also specifies the required performance criteria and pass/fail conditions for both Type 4 and Type 5 indicators.
According to the U.S. Centers for Disease Control and Prevention in November 2025, chemical indicators are recommended inside every sterilization package to verify that items have been exposed to appropriate sterilizing conditions. The CDC further recommends using chemical indicators in combination with mechanical and biological monitoring methods to enhance assurance of sterilization and support effective infection prevention protocols. As a result, increasing awareness of infection prevention is driving wider adoption of chemical indicators across healthcare and allied sectors. Greater emphasis on sterilization validation and patient safety is reinforcing the routine use of these monitoring products. This sustained focus on compliance and quality assurance continues to contribute to steady growth in the chemical indicators market.
U.S. Chemical Indicators Market Report Segmentation
This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. chemical indicators market report based on product, method, and end-use:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Strips
- Indicator Tapes
- Cards
- Others
- Method Outlook (Revenue, USD Million, 2021 - 2033)
- Steam Sterilization
- Ethylene Oxide Sterilization
- Hydrogen Peroxide Sterilization
- Others
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals and Clinics
- Biopharma/Biotech Companies
- Ambulatory Surgery Centers
- Research and Academic Institutes
- Other End Use
Table of Content
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Method
- 1.1.3. End Use
- 1.1.4. Estimates And Forecast Timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.3.5. Details Of Primary Research
- 1.4. Information or Data Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity Price Analysis (Model 1)
- 1.6.2. Approach 1: Commodity Flow Approach
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Chemical Indicators Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising surgical procedure volume
- 3.2.1.2. Growing focus on infection prevention
- 3.2.1.3. Increase in surgical and diagnostic procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of advanced indicators
- 3.2.2.2. Preference for biological indicators
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Increasing focus on infection prevention
- 3.2.3.2. Expansion into non-healthcare sectors
- 3.2.3.3. Increasing number of clinical trials
- 3.2.3.4. Technological advancements
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Competition from alternative technologies
- 3.2.4.2. Variable regulatory requirements
- 3.2.1. Market Driver Analysis
- 3.3. U.S. Chemical Indicators Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's Five Forces
Chapter 4. U.S. Chemical Indicators Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Chemical Indicators Market Product Movement Analysis
- 4.3. U.S. Chemical Indicators Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
- 4.4. Strips
- 4.4.1. Strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Indicator Tapes
- 4.5.1. Indicator tapes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Cards
- 4.6.1. Cards market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.7. Others
- 4.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Chemical Indicators Market: Method Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Chemical Indicators Market Method Movement Analysis
- 5.3. U.S. Chemical Indicators Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
- 5.4. Steam Sterilization
- 5.4.1. Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. Ethylene Oxide Sterilization
- 5.5.1. Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6. Hydrogen Peroxide Sterilization
- 5.6.1. Hydrogen peroxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others Market Estimates and Forecasts for 2021 to 2033, (USD Million)
Chapter 6. U.S. Chemical Indicators Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Chemical Indicators Market End Use Movement Analysis
- 6.3. U.S. Chemical Indicators Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
- 6.4. Hospitals and Clinics
- 6.4.1. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Biopharma/Biotech Companies
- 6.5.1. Biopharma/biotech companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6. Ambulatory Surgery Centers
- 6.6.1. Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.7. Research and Academic Institutes
- 6.7.1. Research and academic institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.8. Other End-Use
- 6.8.1. Other end-use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Innovators
- 7.3. Vendor Landscape
- 7.3.1. Key company market share analysis, 2025
- 7.3.2. Propper Manufacturing Co.
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Usage benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. STERIS
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Usage benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. ASP
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Usage benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Solventum
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Usage benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Getinge
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Usage benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Tuttnauer
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Usage benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Andersen Sterilizers
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Usage benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Mesa Laboratories, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Usage benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Hu-Friedy Mfg. Co.
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Usage benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. True Indicating
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Usage benchmarking
- 7.3.11.4. Strategic initiatives
List of Tables
- Table 1. List of secondary sources
- Table 2. List of abbreviations
- Table 3. U.S. chemical indicators market, by country, 2021 - 2033 (USD Million)
- Table 4. U.S. chemical indicators market, by product, 2021 - 2033 (USD Million)
- Table 5. U.S. chemical indicators market, by method, 2021 - 2033 (USD Million)
- Table 6. U.S. chemical indicators market, by end use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Information Procurement
- Fig. 2 Primary Research Pattern
- Fig. 3 Market Research Approaches
- Fig. 4 Value Chain-Based Sizing & Forecasting
- Fig. 5 Market Formulation & Validation
- Fig. 6 U.S. Chemical Indicators Market, Market Segmentation
- Fig. 7 Market Driver Analysis (Current & Future Impact)
- Fig. 8 Market Restraint Analysis (Current & Future Impact)
- Fig. 9 Market Opportunity Analysis (Current & Future Impact)
- Fig. 10 Market Challenge Analysis (Current & Future Impact)
- Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 12 Porter's Five Forces Analysis
- Fig. 13 U.S. Chemical Indicators market: Product movement analysis
- Fig. 14 Strips market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 15 Indicator tapes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 16 Cards market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 17 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 18 U.S. Chemical Indicators Market: Method Movement Analysis
- Fig. 19 Steam sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 20 Ethylene oxide sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 21 Hydrogen peroxide sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 23 Dental implant market: End Use Movement Analysis
- Fig. 24 Hospitals and clinics market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 25 Biopharma/biotech companies market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 26 Ambulatory surgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 27 Research and academic institutes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
- Fig. 28 Other end-use market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
